Asset Management One Increases Stake in The Cooper Companies by 3.2%

Asset Management One Co. Ltd. has increased its position in The Cooper Companies, Inc. by 3.2%, as disclosed in its latest 13F filing with the Securities and Exchange Commission (SEC). The firm now owns a total of 88,313 shares of the medical device company, having acquired an additional 2,746 shares during the second quarter. As of the most recent filing, these holdings are valued at approximately $6.28 million.

Multiple hedge funds have also adjusted their stakes in The Cooper Companies. Horizon Investments LLC raised its holdings by 5.0% in the first quarter, now owning 2,859 shares valued at $241,000. Similarly, Axxcess Wealth Management LLC increased its position by 1.9%, bringing its total to 7,382 shares worth $623,000, while Wealth Alliance LLC’s stake grew by 5.5% to 4,059 shares valued at $342,000. EverSource Wealth Advisors LLC also increased its holdings by 3.5%, now owning 6,517 shares valued at $550,000. Hardy Reed LLC raised its stake by 4.1% during the second quarter, resulting in ownership of 6,213 shares valued at $442,000. Overall, hedge funds and institutional investors now hold approximately 24.39% of the company’s stock.

In terms of insider activity, Executive Vice President Brian G. Andrews purchased 1,525 shares on September 2 at an average price of $65.68 per share, totaling $100,162. Following this transaction, Andrews’ ownership increased to 22,191 shares, valued at around $1.46 million. Similarly, Chief Operating Officer Gerard H. Warner III acquired 1,450 shares on September 5 for an average price of $69.23, amounting to $100,383.50. After this purchase, Warner’s total holdings increased to 18,319 shares, valued at approximately $1.27 million. Collectively, insiders have acquired 17,975 shares of company stock worth $1.22 million in the last quarter, representing 1.98% of total ownership.

Market Analysts Offer Insights

Recent commentary from equities research analysts reflects diverse opinions on The Cooper Companies. Mizuho lowered its target price from $105.00 to $90.00 while maintaining an “outperform” rating. Conversely, BNP Paribas Exane upgraded the stock from “neutral” to “outperform” with a new price objective of $92.00. Piper Sandler revised its target down from $105.00 to $83.00, also maintaining an “overweight” rating. Likewise, JPMorgan Chase & Co. adjusted its price target from $76.00 to $66.00 with a “neutral” rating.

Analysts’ ratings show one “Strong Buy,” ten “Buy,” three “Hold,” and one “Sell” rating for The Cooper Companies. According to MarketBeat, the stock currently holds an average rating of “Moderate Buy” with a consensus target price of $84.77.

Current Stock Performance and Financial Outlook

As of Wednesday, The Cooper Companies’ stock opened at $71.75, with a market capitalization of $14.26 billion. The company has a price-to-earnings ratio of 35.35 and a PEG ratio of 1.91. Its 50-day moving average stands at $69.61, while the 200-day moving average is at $73.16. The stock has experienced a 52-week low of $61.78 and a high of $107.84.

The Cooper Companies recently reported its earnings for the quarter ending August 27, showing earnings per share (EPS) of $1.10, surpassing the consensus estimate of $1.07. The company generated revenue of $1.06 billion, matching analyst expectations. Year-over-year revenue growth stood at 5.7%, with a return on equity of 9.82% and a net margin of 10.08%. Looking ahead, The Cooper Companies has set guidance for Q4 2025 at $1.100-$1.140 EPS, with full-year guidance of $4.080-$4.120 EPS. Analysts predict an EPS of $3.98 for the current year.

In a strategic move, The Cooper Companies’ board has announced a share buyback plan on September 17, authorizing the company to repurchase up to $2.00 billion in shares, representing approximately 15.4% of its stock. Such buyback plans typically indicate a belief by the board that the company’s shares are undervalued.

The Cooper Companies, which operates through its subsidiaries, develops, manufactures, and markets products for contact lens wearers. The company is divided into two segments: CooperVision and CooperSurgical, with the former providing various types of lenses designed to address vision challenges across global markets.